Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2017 · 51 citations · 27 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerCancer BioinformaticsDual-luciferase AssaysLuciferase Reporter AssaysMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna TargetingWestern Blot Analysis
Recent studies suggest that microRNAs (miRNAs) are critical regulators in many types of cancer, including osteosarcoma. miR-342-3p has emerged as an important cancer-related miRNA in several types of cancers. However, the functional significance of miR-342-3p in osteosarcoma is unknown. The aims of this study were to investigate whether miR-342-3p is dysregulated in osteosarcoma and to explore the biological function of miR-342-3p in regulating cellular processes of osteosarcoma cells. We found that miR-342-3p expression was significantly decreased in osteosarcoma tissues and cell lines. Overexpression of miR-342-3p inhibits the proliferation, migration, and invasion of osteosarcoma cells. In contrast, the inhibition of miR-342-3p exhibited the opposite effect. Astrocyte-elevated gene-1 (AEG-1) was identified as one of the target genes of miR-342-3p in osteosarcoma cells by bioinformatics analysis, dual-luciferase reporter assay, real-time quantitative polymerase chain reaction, and Western blot analysis. Overexpression of miR-342-3p also inhibited the Wnt and nuclear factor κB signaling pathways. Moreover, overexpression of AEG-1 partially rescued the inhibitory effects of miR-342-3p mediated on the proliferation, migration, and invasion of osteosarcoma cells. Overall, our results show that miR-342-3p inhibits the proliferation, migration, and invasion of osteosarcoma cells through targeting AEG-1, suggesting a potential target for the development of miRNA-based therapy for osteosarcoma.
27
X-X He, Ying Chang, M-Y Wang et al. · Oncogene · 2011 · 341 citations · Full text
Zao-zhong Su, Dong‐Chul Kang, Yinming Chen et al. · Oncogene · 2002 · 315 citations